Craig Thompson has joined Neurana Pharmaceuticals as president and CEO. Prior to starting at the San Diego company, Thompson was president and CEO of Anthera Pharmaceuticals in Hayward, CA. Neurana develops drugs that treat neuromuscular conditions. In May, the company closed a $60 million Series A round of funding to finance Phase 2 studies testing tolperisone, a relaxant to treat muscles spasms without causing sedation.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
